- Degree Bachelor
- Code: CCS042
- Credit hrs: 2
- Prequisites: CCS121, CCS241
This course provides students with a comprehensive overview of the fundamentals of pharmacogenomics and the influence of genetic variability on drug response and clinical pharmacology. It examines the relationships between human genetic variation and drug responsiveness, susceptibility to disease, and disease severity. The course also addresses the application of pharmacogenomics to drug discovery, clinical development, and personalized medicine.
Students will develop foundational skills in interpreting pharmacogenomic test results, evaluating scientific literature, and using evidence-based guidelines to support individualized therapeutic decisions. The course further explores the scientific, clinical, legal, and ethical challenges associated with the implementation of pharmacogenomics, including the interpretation and appropriate use of genetic information. The practical component emphasizes simulated test-report interpretation, literature appraisal, clinical case analysis, and the application of pharmacogenomic principles to selected therapeutic situations.
Bachelor of Pharmacy - PharmD (Clinical Pharmacy)
|
1.1 |
Explain the fundamental concepts of pharmacogenomics and the role of human genetic variability in drug response. |
|
1.2 |
Describe how pharmacogenomic variation may influence drug pharmacokinetics, pharmacodynamics, therapeutic efficacy, dosage requirements, and adverse drug reactions. |
|
1.3 |
Explain the relationships between human genetic variability, drug responsiveness, susceptibility to disease, and disease severity. |
|
1.4 |
Interpret simulated pharmacogenomic test results and relate relevant genetic findings to potential clinical implications and individualized therapeutic decisions. |
|
1.5 |
Retrieve and critically evaluate pharmacogenomic literature and apply relevant evidence-based guidelines to selected clinical scenarios. |
|
1.6 |
Discuss the scientific, clinical, and regulatory challenges associated with applying pharmacogenomics in drug discovery and clinical development. |
|
1.7 |
Discuss relevant ethical, legal, and safety considerations associated with pharmacogenomic testing and the use of genetic information in personalized medicine. |
|
1.8 |
Analyze selected pharmacogenomic cases by integrating genetic findings and available evidence to support reasoned, individualized therapeutic recommendations. |
1. Current pharmacology textbooks covering clinical pharmacology, drug metabolism, pharmacodynamics, and individualized therapy. 2. Current human genetics and pharmacogenomics textbooks or authoritative academic references.
| content serial | Description |
|---|
| 1 | Introduction to pharmacogenomics: definitions, scope, historical development, and role in personalized medicine. |
| 2 | Fundamentals of human genetics and genetic variation relevant to drug response. |
| 3 | Genetic variation and drug pharmacokinetics, including drug-metabolizing enzymes and transporters. |
| 4 | Genetic variation and pharmacodynamics, drug targets, and variability in therapeutic response. |
| 5 | Pharmacogenomics and drug efficacy, adverse drug reactions, dosage requirements, and clinical pharmacology. |
| 6 | Relationships between genetic variability, disease susceptibility, disease severity, and treatment outcomes. |
| 7 | Pharmacogenomic testing: principles, applications, limitations, and sources of uncertainty. |
| 8 | Interpretation of pharmacogenomic test results and their potential clinical implications. |
| 9 | Pharmacogenomic literature: research designs, evidence quality, and critical appraisal. |
| 10 | Evidence-based pharmacogenomic guidelines and their use in therapeutic decision-making. |
| 11 | Application of pharmacogenomics in drug discovery and preclinical research. |
| 12 | Pharmacogenomics in clinical development: efficacy, safety, and regulatory considerations. |
| 13 | Pharmacogenomics and personalized medicine: individualized treatment selection and optimization. |
| 14 | Scientific, clinical, legal, and ethical challenges, including genetic-data privacy and informed consent. |
| 15 | Integrated pharmacogenomic case studies, evidence-based recommendations, and course review. |
Start your application